Object structure
Title:

Public perception of innovative therapies and biopharmaceuticals in Poland and Europe

Subtitle:

Public perception of innovative therapies and biopharmaceuticals in Poland and Europe

Creator:

Szlichcińska, Joanna

Publisher:

Committee on Biotechnology PAS ; Institute of Bioorganic Chemistry PAS

Date issued/created:

2007

Subject and Keywords:

biotechnology

Abstract:

Several reports and surveys of the perception of red biotechnology uses conducted in recent years show the complexity of European’s attitude to innovative therapies which might be used in medicine. Polish people, as well as the rest of European nations in general, support the development of gene therapy or pharmacogenetics, whereas the issues of stem cells research and uses of genetic information are still under discussion. The results of various questionnaires prove that a rise of the optimism level in this matter is necessary. It occurred that in order to build public acceptability and confidence in biotechnology policy, it is crucial to ensure the society that moral and ethical aspects are taken into consideration.

Relation:

Biotechnologia, vol.77, 2 (2007)-.

Volume:

77

Issue:

2

Start page:

128

End page:

136

Resource type:

Text

Detailed Resource Type:

Article

Format:

application/pdf

Resource Identifier:

0860-7796

Source:

Library of Institute of Bioorganic Chemistry PAS

Language:

pol

Language of abstract:

eng

Temporal coverage:

1988-2010

Rights:

Creative Commons Attribution BY-SA 4.0 license

Terms of use:

Copyright-protected material. [CC BY-SA 4.0] May be used within the scope specified in Creative Commons Attribution BY-SA 4.0 license, full text available at:

Digitizing institution:

Institute of Bioorganic Chemistry of the Polish Academy of Science

Original in:

Institute of Bioorganic Chemistry of the Polish Academy of Science

Projects co-financed by:

Operational Program Digital Poland, 2014-2020, Measure 2.3: Digital accessibility and usefulness of public sector information; funds from the European Regional Development Fund and national co-financing from the state budget.

Access:

Open

×

Citation

Citation style: